Hyperfine, Inc. (HYPR)

0.7917 +0.02 (+2.45%) USD  |  NASDAQ  |  Sep 18, 16:00
0.7665 -0.03 (-3.18%) After-Hours: 20:00
More

Hyperfine Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for HYPR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Quarter Chart
Start Trial

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
September 15, 2026 --
September 14, 2026 --
August 20, 2026 --
August 10, 2026 --
August 07, 2026 --
July 13, 2026 --
May 26, 2026 --
May 13, 2026 --
May 12, 2026 --
April 29, 2026 --
March 19, 2026 --
November 14, 2025 --
August 14, 2025 --
June 13, 2025 --
Date Value
June 03, 2025 --
May 14, 2025 --
May 13, 2025 --
March 24, 2025 --
March 19, 2025 --
March 18, 2025 --
March 17, 2025 --
February 11, 2025 --
August 09, 2024 --
May 14, 2024 --
May 13, 2024 --
April 09, 2024 --
March 22, 2024 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Abbott Laboratories Upgrade
AngioDynamics, Inc. Upgrade
Alphatec Holdings, Inc. Upgrade
AtriCure, Inc. Upgrade
Baxter International, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade